Interleukin-6 Removal and Clinical Effects of Oxiris: A Systematic Review and Meta-Analysis
Blood Purification · 28.07.2025 · 55 (6-7) · 454-463
DOI: 10.1159/000547587 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Blood Purification, online erschienen am 28.07.2025. Verfasst von Arnau Ulsamer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. Hauptthemen laut MEDLINE: Interleukin-6, Sepsis, COVID-19, Hemofiltration. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Introduction
Sepsis is a life-threatening condition associated with high mortality due to an unregulated host immune response. Extracorporeal blood purification (EBP) therapies have been proposed as adjunctive treatments to immunomodulate patients; however, none have been consistently shown to be effective in reducing mortality. In several observational studies, Oxiris has been associated with cytokine reduction and a potential benefit in influencing inflammatory diseases. This meta-analysis explores the association between cytokine removal and clinical efficacy of the Oxiris membrane using interleukin-6 (IL-6) as a biomarker.
Methods
This review includes articles on EBP with Oxiris membranes in adult patients with sepsis/septic shock or COVID-19. No time or language restrictions were applied to the systematic literature search. Data extraction and statistical analysis were limited to the cytokines and clinical data reported in the included articles. The most representative cytokine was IL-6 and the selected outcomes included Vasoactive-Inotropic Score (VIS), SOFA score, procalcitonin (PCT) and C-reactive protein (CRP). The review used meta-analysis and unpaired t test to estimate differences between groups of patients treated with or without Oxiris.
Results
The study found no significant differences in demographics between the intervention and control groups at baseline. Intervention group showed a significant reduction in vasoactive inotropic score, norepinephrine dose, SOFA score, PCT, and CRP.
Conclusion
We reviewed 8 studies in which IL-6 was significantly reduced in the Oxiris group compared to the control. This meta-analysis found that the use of the Oxiris membrane resulted in significant clinical improvement during treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
- Department of Health Sciences, Section of Anesthesiology and Intensive Care, University of Florence, Florence, Italy.
- Departamento de ortopedia y traumatología, Universidad El Bosque, Bogota, Colombia.
- Department of Statistics, Informatics, Applications, University of Florence, Florence, Italy.
- Department of General Anesthesia and Intensive Care, IRCCS Polyclinic San Donato, San Donato M.se, Milan, Italy.
- Department of Anesthesia and Intensive Care, Section of Oncological Anesthesia and Intensive Care, AOU Careggi, Florence, Italy.
Zitieren
APA
Ulsamer, A., Pomarè Montin, D., Bocciero, V., Parra Morales, T. J., Tofani, L., di Girolamo, L., Romagnoli, S., Villa, G., & Cecchi, M. (2025). Interleukin-6 Removal and Clinical Effects of Oxiris: A Systematic Review and Meta-Analysis. Blood Purification, 55(6-7), 454-463. https://doi.org/10.1159/000547587
Vancouver
Ulsamer A, Pomarè Montin D, Bocciero V, Parra Morales TJ, Tofani L, di Girolamo L, et al. Interleukin-6 Removal and Clinical Effects of Oxiris: A Systematic Review and Meta-Analysis. Blood Purification. 2025;55(6-7):454-463. doi:10.1159/000547587
BibTeX
@article{Ulsamer2025,
author = {Ulsamer, Arnau and Pomarè Montin, Diego and Bocciero, Vittorio and Parra Morales, Tania Julieth and Tofani, Lorenzo and di Girolamo, Luca and Romagnoli, Stefano and Villa, Gianluca and Cecchi, Matteo},
title = {Interleukin-6 Removal and Clinical Effects of Oxiris: A Systematic Review and Meta-Analysis},
journal = {Blood Purification},
year = {2025},
volume = {55},
number = {6-7},
pages = {454--463},
doi = {10.1159/000547587}
}
EUVIMED